Immunology

This new program was designed to be a scalable model for the formulation of similar initiatives in communities known to have limited access to specialized care for rheumatic conditions.

New data presented at ACR 2023 highlighted the differences in rates of flares and Boolean 2.0 remission rates compared to patients with rheumatoid arthritis who continued a tumor necrosis factor inhibitor (TNFi).

A nationwide cohort study linked biologic disease-modifying antirheumatic drugs with decreased risks for the onset of autoimmune thyroid disease in patients with rheumatoid arthritis.

In a cross-sectional study, insulin growth factor binding protein 2 (IFGBP-2) showed promise as a prognosis biomarker for renal disease in pediatric lupus nephritis (LN).

Patients with SLE who reported being more satisfied in their lives were more likely to have higher physical and mental component summary scores.

Vitamin D deficiency is associated with high inflammation and bone mineral density (BMD) decline in patients with systemic lupus erythematosus (SLE).

Adults at or under the age of 65 years who are frail and have systemic lupus erythematosus (SLE) increased the likelihood of repeated emergency department visits.

A study suggests that strains of ruminococcus (blautia) gnavus (RG) seen in the gut microbiome of patients in active lupus nephritis might be drivers of disease flares and highlight the possible pathogenic qualities of specific strains.